Czifra G et al. |
Endocannabinoids regulate growth and survival of human eccrine sweat gland-derived epithelial cells. |
2012 |
J. Invest. Dermatol. |
pmid:22513781
|
Turcotte C et al. |
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. |
2015 |
J. Leukoc. Biol. |
pmid:25877930
|
Oka S et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. |
2004 |
J. Leukoc. Biol. |
pmid:15316028
|
Jackson AR et al. |
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. |
2014 |
J. Leukoc. Biol. |
pmid:24319288
|
Glass M et al. |
Misidentification of prostamides as prostaglandins. |
2005 |
J. Lipid Res. |
pmid:15863842
|
Newberry EP et al. |
Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. |
2012 |
J. Lipid Res. |
pmid:22327204
|
Ambrosi S et al. |
On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity. |
2005 |
J. Lipid Res. |
pmid:15961786
|
Bojesen IN and Hansen HS |
Membrane transport of anandamide through resealed human red blood cell membranes. |
2005 |
J. Lipid Res. |
pmid:15930521
|
Weber A et al. |
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. |
2004 |
J. Lipid Res. |
pmid:14729864
|
Kantae V et al. |
Quantitative profiling of endocannabinoids and related -acylethanolamines in human CSF using nano LC-MS/MS. |
2017 |
J. Lipid Res. |
pmid:27999147
|
Long JZ et al. |
An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. |
2011 |
J. Lipid Res. |
pmid:21097653
|
Oddi S et al. |
Pitfalls and solutions in assaying anandamide transport in cells. |
2010 |
J. Lipid Res. |
pmid:20447929
|
Fezza F et al. |
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. |
2008 |
J. Lipid Res. |
pmid:18316795
|
Bojesen IN and Hansen HS |
Binding of anandamide to bovine serum albumin. |
2003 |
J. Lipid Res. |
pmid:12837852
|
Jacome-Sosa M et al. |
Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat. |
2016 |
J. Lipid Res. |
pmid:26891736
|
Yang W et al. |
Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. |
2005 |
J. Lipid Res. |
pmid:16150817
|
Patel S et al. |
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. |
2005 |
J. Lipid Res. |
pmid:15576840
|
Bojesen IN and Hansen HS |
Effect of an unstirred layer on the membrane permeability of anandamide. |
2006 |
J. Lipid Res. |
pmid:16365480
|
Wollank Y et al. |
Inhibition of FAAH confers increased stem cell migration via PPARα. |
2015 |
J. Lipid Res. |
pmid:26263913
|
Clugston RD et al. |
Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. |
2011 |
J. Lipid Res. |
pmid:21856784
|
Markey SP et al. |
Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses. |
2000 |
J. Lipid Res. |
pmid:10744787
|
Hillard CJ and Campbell WB |
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. |
1997 |
J. Lipid Res. |
pmid:9458263
|
Astarita G et al. |
Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. |
2008 |
J. Lipid Res. |
pmid:17957091
|
De Petrocellis L et al. |
Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide. |
2009 |
J. Lipid Res. |
pmid:19017617
|
McAllister SD et al. |
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. |
2003 |
J. Med. Chem. |
pmid:14613317
|
Lambert DM and Fowler CJ |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. |
2005 |
J. Med. Chem. |
pmid:16078824
|
Vandevoorde S et al. |
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase. |
2003 |
J. Med. Chem. |
pmid:14521402
|
Ng EW et al. |
Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. |
1999 |
J. Med. Chem. |
pmid:10354405
|
Schiano Moriello A et al. |
Development of the first potential covalent inhibitors of anandamide cellular uptake. |
2006 |
J. Med. Chem. |
pmid:16570928
|
Appendino G et al. |
Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. |
2006 |
J. Med. Chem. |
pmid:16570929
|
Tarzia G et al. |
Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. |
2003 |
J. Med. Chem. |
pmid:12773040
|
López-RodrÃguez ML et al. |
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. |
2003 |
J. Med. Chem. |
pmid:12672252
|
Tuccinardi T et al. |
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. |
2006 |
J. Med. Chem. |
pmid:16451064
|
Balas L et al. |
Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity. |
2009 |
J. Med. Chem. |
pmid:19161308
|
Hanus L et al. |
Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. |
1993 |
J. Med. Chem. |
pmid:8411021
|
Cisneros JA et al. |
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17764163
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
MartÃn-Couce L et al. |
Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors. |
2011 |
J. Med. Chem. |
pmid:21675776
|
Romero FA et al. |
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17279740
|
Salo OM et al. |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. |
2006 |
J. Med. Chem. |
pmid:16420041
|
Avraham Y et al. |
Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY). |
2013 |
J. Med. Chem. |
pmid:23384387
|
Onnis V et al. |
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. |
2010 |
J. Med. Chem. |
pmid:20143779
|
Li C et al. |
High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. |
2005 |
J. Med. Chem. |
pmid:16190768
|
van der Stelt M et al. |
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. |
2002 |
J. Med. Chem. |
pmid:12166944
|
López-RodrÃguez ML et al. |
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. |
2001 |
J. Med. Chem. |
pmid:11741470
|
Seltzman HH et al. |
Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. |
1997 |
J. Med. Chem. |
pmid:9357529
|
Lin S et al. |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. |
1998 |
J. Med. Chem. |
pmid:9876105
|
Fichera M et al. |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. |
2000 |
J. Med. Chem. |
pmid:10882356
|
Brizzi A et al. |
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor. |
2011 |
J. Med. Chem. |
pmid:22044209
|
Ortar G et al. |
New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. |
2007 |
J. Med. Chem. |
pmid:18027904
|
Ryan WJ et al. |
Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. |
1997 |
J. Med. Chem. |
pmid:9357528
|
Appendino G et al. |
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. |
2009 |
J. Med. Chem. |
pmid:19361197
|
Thomas BF et al. |
Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. |
1996 |
J. Med. Chem. |
pmid:8558515
|
Brizzi A et al. |
New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. |
2009 |
J. Med. Chem. |
pmid:19331413
|
Sheskin T et al. |
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. |
1997 |
J. Med. Chem. |
pmid:9057852
|
Feledziak M et al. |
SAR and LC/MS studies of β-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process. |
2011 |
J. Med. Chem. |
pmid:21899370
|
Lang W et al. |
Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. |
1999 |
J. Med. Chem. |
pmid:10072686
|
Brizzi A et al. |
Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors. |
2005 |
J. Med. Chem. |
pmid:16279794
|
Khanolkar AD et al. |
Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. |
1996 |
J. Med. Chem. |
pmid:8893848
|
Palermo G et al. |
Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas. |
2011 |
J. Med. Chem. |
pmid:21830831
|
Barnett-Norris J et al. |
Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. |
2002 |
J. Med. Chem. |
pmid:12166938
|
Wyffels L et al. |
Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain. |
2009 |
J. Med. Chem. |
pmid:19719235
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Vandevoorde S et al. |
Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide. |
2003 |
J. Med. Chem. |
pmid:12672243
|
Lynch DL and Reggio PH |
Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics. |
2005 |
J. Med. Chem. |
pmid:16033262
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Amorós I et al. |
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. |
2010 |
J. Mol. Cell. Cardiol. |
pmid:19616555
|
Weis F et al. |
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. |
2010 |
J. Mol. Cell. Cardiol. |
pmid:19931541
|
Hoyer FF et al. |
Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice. |
2014 |
J. Mol. Cell. Cardiol. |
pmid:24286707
|
Currie S et al. |
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. |
2008 |
J. Mol. Cell. Cardiol. |
pmid:18692061
|
D'Argenio G et al. |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. |
2007 |
J. Mol. Med. |
pmid:17396241
|
Iuvone T et al. |
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. |
2007 |
J. Mol. Med. |
pmid:17639288
|
Catani MV et al. |
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol. |
2009 |
J. Mol. Med. |
pmid:18820887
|
Wang ZY et al. |
Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase. |
2015 |
J. Mol. Neurosci. |
pmid:25374388
|
Lagalwar S et al. |
Anandamides inhibit binding to the muscarinic acetylcholine receptor. |
1999 Aug-Oct |
J. Mol. Neurosci. |
pmid:10691292
|
Naidoo V et al. |
A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. |
2011 |
J. Mol. Neurosci. |
pmid:21069475
|
Hillard CJ et al. |
Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. |
2007 |
J. Mol. Neurosci. |
pmid:17901541
|
Han B et al. |
Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. |
2003 |
J. Nat. Prod. |
pmid:14575438
|
Raduner S et al. |
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. |
2007 |
J. Nat. Prod. |
pmid:17497806
|
Hillard CJ et al. |
Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. |
1995 |
J. Neurochem. |
pmid:7830060
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Hill MN et al. |
Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. |
2007 |
J. Neurochem. |
pmid:17561935
|
Subbanna S et al. |
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice. |
2015 |
J. Neurochem. |
pmid:25857698
|
Sarker KP et al. |
ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. |
2003 |
J. Neurochem. |
pmid:12641726
|
Wu X et al. |
Alteration of endocannabinoid system in human gliomas. |
2012 |
J. Neurochem. |
pmid:22176552
|
Butt C et al. |
Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. |
2008 |
J. Neurochem. |
pmid:18194436
|
Basavarajappa BS and Hungund BL |
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. |
1999 |
J. Neurochem. |
pmid:9930723
|
De Lago E et al. |
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. |
2006 |
J. Neurochem. |
pmid:16899063
|
Nogueron MI et al. |
Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. |
2001 |
J. Neurochem. |
pmid:11677265
|
Vogel Z et al. |
Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. |
1993 |
J. Neurochem. |
pmid:8515284
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Di Marzo V et al. |
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. |
2000 |
J. Neurochem. |
pmid:10737621
|
Maccarrone M et al. |
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. |
2001 |
J. Neurochem. |
pmid:11461969
|
Mestre L et al. |
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. |
2005 |
J. Neurochem. |
pmid:15748152
|
Oz M et al. |
The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. |
2010 |
J. Neurochem. |
pmid:20050977
|
Rubino T et al. |
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. |
2000 |
J. Neurochem. |
pmid:11080200
|
Wiles AL et al. |
N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. |
2006 |
J. Neurochem. |
pmid:16899062
|
Berger C et al. |
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? |
2004 |
J. Neurochem. |
pmid:15009671
|
De Petrocellis L et al. |
The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. |
2001 |
J. Neurochem. |
pmid:11413249
|
Placzek EA et al. |
Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. |
2008 |
J. Neurochem. |
pmid:18778304
|